Growth Guys Codes
Independent affiliate site. I earn a commission if you use my code, at no extra cost to you. How I check facts

News and research

What is happening in the peptide world, with sources and dates.

News and researchWhat is happening in the peptide world, with sources and dates.Codes and ordersThe discount code, Bitcoin savings, shipping and price math.Buyer safetyVendor checks, lab reports and red flags before you order.Learn the basicsPlain English explainers on labels, storage and the rules.

News and research

Oral peptides: why a pill is so much harder than a shot

Why most peptide drugs are injected, how oral semaglutide gets around the gut, and why a pill can need 10 to 100 times more active ingredient.News from Oct 21, 2026 · 2 min read
News and research

The $71B two-drug race shaping the peptide market

Two weight and diabetes drugs dominate peptide sales. Who is chasing them, which oral peptides are coming, and what to watch, as of October 2026.News from Oct 20, 2026 · 2 min readNews and research

The FDA peptide U-turn, explained in five steps

The US reclassified some peptides in February, a panel overruled FDA staff in July, and a new policy is pending. The timeline, and what it does not mean.News from Oct 15, 2026 · 2 min readNews and research

990 reports: what the FDA numbers on compounded GLP-1s mean

The FDA is tracking hundreds of adverse event reports on compounded weight loss drugs. What a report is, what it is not, and what experts say to ask.News from Sep 4, 2026 · 2 min readNews and research

The GLP-1 compounding story: how it got here

How compounded semaglutide and tirzepatide became a flashpoint: the 2026 FDA restrictions, the adverse event numbers and what regulators say.News from Sep 4, 2026 · 2 min readNews and research

BPC-157: famous online, thin on human evidence

Why a compound can be everywhere on the internet and still lack human trials. What a 2026 report says about the BPC-157 evidence, and how to judge it.News from Aug 21, 2026 · 2 min readNews and research

A US peptide seller was sentenced: what to learn

A US peptide company owner was sentenced to 70 months in 2026 for selling unapproved drugs with false lab certificates. The lessons for checking a COA.News from Aug 3, 2026 · 2 min readNews and research

Canadian experts: peptide hype is outpacing the research

In July 2026 Canadian professors told CP24 that few peptides have proven benefits and criticized the FDA panel vote. Who said what, and what Health Canada said.News from Jul 30, 2026 · 2 min readNews and research

A Canadian court just shut down an online peptide seller

A Québec court order bars an online seller from selling unauthorized injectable peptides. What happened, and why a research label did not settle it.News from Jul 29, 2026 · 2 min readNews and research

Health Canada vs the FDA: two very different peptide paths

In 2026 the US loosened some peptide compounding while Canada went to court. A side by side look at how the two regulators are moving.News from Jul 29, 2026 · 2 min readNews and research

BPC-157 in Canada: what Health Canada says

Health Canada says BPC-157 has not been authorized and its safety and quality are unassessed. The July 2026 report and the gap it describes.News from Jul 27, 2026 · 2 min readNews and research

The FDA peptide panel vote, scorecard style

The July 2026 FDA panel vote on seven peptides, tally by tally, plus what has to happen before anything changes for pharmacies.News from Jul 24, 2026 · 2 min readNews and research

Swiss regulators check 46 peptide parcels

A June 2026 Swiss campaign inspected suspicious peptide packages. Half were held, most came from one country, and labels often could not be trusted.News from Jun 30, 2026 · 2 min readNews and research

Retatrutide phase 3: the numbers, and the fine print

Lilly reported large weight loss in the TRIUMPH-1 trial. The headline numbers, the side effects, and why a trial result says nothing about other vials.News from May 21, 2026 · 2 min readNews and research

Dr. Reddy's launches generic semaglutide in Canada

Dr. Reddy's launched a generic semaglutide pen in Canada in May 2026 after Health Canada approval. Strengths, status and what is still pending. Facts only.News from May 16, 2026 · 2 min readNews and research

Canada approves the first generic Ozempic

Health Canada approved a generic semaglutide in April 2026, a G7 first. The price rules, the review timeline and what is still pending.News from Apr 28, 2026 · 2 min readNews and research

FDA removed 12 peptides from Category 2: what changed

On April 15, 2026 the FDA removed 12 peptides from its Category 2 list. A law firm says that did not make any peptide eligible for compounding. The timeline.News from Apr 15, 2026 · 2 min readNews and research

Health Canada: a research-use-only label does not make it legal

Health Canada's April 2026 advisory names 14 peptides and says a research-use-only label does not make a product legal. What it says and how to check a DIN.News from Apr 9, 2026 · 2 min readNews and research

Retatrutide in Canada: legal status and what to know

Is retatrutide legal in Canada? Health Canada's April 2026 advisory lists it as an unauthorized injectable. What that means and how to check a drug yourself.News from Apr 9, 2026 · 2 min readNews and research

Clinical trial phases 1, 2 and 3: what each one proves

A plain English guide to trial phases, with real examples from retatrutide and an oral weight loss program, and why phase 3 still is not the end.2 min readNews and research

From Gila monster venom to GLP-1 drugs

How a researcher studying Gila monster venom found exendin-4 in the 1990s, and why a molecule that lasts hours mattered for diabetes drugs.2 min readNews and research

How a peptide is made, in plain English

Peptides are built one amino acid at a time on a solid support, then purified. Why yield falls for long chains and why purity testing exists.2 min readNews and research

How to read peptide news without getting fooled

Seven quick checks for any peptide headline: who reported it, animals or humans, which phase, and why an advisory vote is not an approval.2 min readNews and research

A short history of peptide drugs: 1922 to today

From insulin in 1922 to oral semaglutide and tirzepatide: a timeline of the peptide drugs that shaped modern medicine, with the key numbers.2 min readNews and research

How a lapsed patent opened Canada to generic semaglutide

Reports say Novo Nordisk let its Canadian semaglutide patent lapse in 2020. The dates, the analyst view and what it means for prices.2 min read
Growth Guys Codes
CodeDEAL10
Copy code and shop